IL277033A - Thrombin solution and methods of use thereof - Google Patents
Thrombin solution and methods of use thereofInfo
- Publication number
- IL277033A IL277033A IL277033A IL27703320A IL277033A IL 277033 A IL277033 A IL 277033A IL 277033 A IL277033 A IL 277033A IL 27703320 A IL27703320 A IL 27703320A IL 277033 A IL277033 A IL 277033A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- thrombin solution
- thrombin
- solution
- Prior art date
Links
- 108090000190 Thrombin Proteins 0.000 title 1
- 229960004072 thrombin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL22339612 | 2012-12-03 | ||
| US201361753542P | 2013-01-17 | 2013-01-17 | |
| PCT/IL2013/000088 WO2014087394A1 (en) | 2012-12-03 | 2013-11-28 | Thrombin solution and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL277033A true IL277033A (en) | 2020-10-29 |
| IL277033B1 IL277033B1 (en) | 2024-01-01 |
| IL277033B2 IL277033B2 (en) | 2024-05-01 |
Family
ID=67068240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL277033A IL277033B2 (en) | 2012-12-03 | 2013-11-28 | Thrombin solution and methods of use thereof |
Country Status (4)
| Country | Link |
|---|---|
| KR (1) | KR102223275B1 (en) |
| ES (1) | ES2828498T3 (en) |
| IL (1) | IL277033B2 (en) |
| NZ (1) | NZ708737A (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1927658B1 (en) * | 2004-06-22 | 2012-10-10 | Zymogenetics, Inc. | Thrombin compositions |
| ES2226587B1 (en) * | 2004-10-22 | 2005-12-16 | Probitas Pharma, S.A. | STABLE THROMBINE COMPOSITION. |
| DK2252335T3 (en) * | 2008-03-03 | 2013-07-08 | Omrix Biopharmaceuticals Ltd | GELATIN FUNGI, INCLUDING AN ACTIVE INGREDIENT, MANUFACTURING AND USING THEREOF |
| IL207586A0 (en) * | 2010-08-12 | 2010-12-30 | Omrix Biopharmaceuticals Ltd | A fibrin based therapeutic preparation and use thereof |
-
2013
- 2013-11-28 KR KR1020207010110A patent/KR102223275B1/en active Active
- 2013-11-28 IL IL277033A patent/IL277033B2/en unknown
- 2013-11-28 NZ NZ708737A patent/NZ708737A/en not_active IP Right Cessation
- 2013-11-28 ES ES13820993T patent/ES2828498T3/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102223275B1 (en) | 2021-03-09 |
| NZ708737A (en) | 2019-06-28 |
| IL277033B1 (en) | 2024-01-01 |
| KR20200039831A (en) | 2020-04-16 |
| IL277033B2 (en) | 2024-05-01 |
| ES2828498T3 (en) | 2021-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201609940RA (en) | Compounds and their methods of use | |
| ZA201502503B (en) | Hppd variants and methods of use | |
| IL239353A0 (en) | Continuous extraction unit and methods making use of same | |
| IL235436A0 (en) | Anti-pcsk9 compositions and use thereof | |
| SI2909204T1 (en) | Gsk3 inhibitors and methods of use thereof | |
| ZA201405858B (en) | Recombinant microorganisms and methods of use thereof | |
| ZA201404675B (en) | Anti-lrp5 antibodies and methods of use | |
| EP2790709A4 (en) | Hemostatic agents and methods of use | |
| SG10201707813YA (en) | Cd40l-specific tn3-derived scaffolds and methods of use thereof | |
| EP2806811A4 (en) | Vertebral construct and methods of use | |
| IL233481A0 (en) | Peptides and methods of using same | |
| ZA201406082B (en) | Use of ccr3-inhibitors | |
| IL239043B (en) | Thrombin solution and methods of use thereof | |
| ZA201405829B (en) | Cleaning arrangement and method of use | |
| PL2864417T3 (en) | Polymer and method of use | |
| ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
| ZA201405644B (en) | Weatherised minerals and methods of making and using same | |
| EP2859071A4 (en) | Chemical compositions and methods of using same | |
| IL277033A (en) | Thrombin solution and methods of use thereof | |
| GB201316230D0 (en) | Catalysts and methods of making and using catalysts |